Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
10 Activities to Lift Your Consume and Bust Your Stomach - 2The Electric Bicycle Americans Can Confide in 2024
- 3The Appearance of Experience: Embracing the Reduced Portage Horse
- 4Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- 5We may be witnessing the messy death of a star in real time
- Civil rights leader Jesse Jackson hospitalized, family requests prayers
- Manual for Conservative SUVs For Seniors
- Moving Wedding Objections for Paramount Functions
- The most effective method to Pick the Right Old Consideration Administration: Key Contemplations
- 5 Pizza Fixings That Characterize Your Character
- One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- Nations for Youngsters to Visit
- Hypothermia claims newborn in Gaza and more babies are at risk, doctor says
- Europe pledges over €15bn for clean energy for Africa
